New device IDs disease-causing germs

(HealthDay)—A new spectrometer system designed to identify 193 yeast and bacteria that are capable of making people sick has been approved by the U.S. Food and Drug Administration.

The Vitek MS can screen for yeasts such as Candida and Malassezia and bacteria from the Staphylococcaceae and pneumonia families, the agency said in a news release. People with AIDS and others with are most prone to infections from these germs.

The device uses a laser to break germs into pattern-forming particles that are unique to each or bacterium, the FDA said. Only a small amount is necessary to identify these germs, which collectively are responsible for skin, bloodstream and respiratory infections.

In clinical testing, the new device correctly identified a germ's scientific group or family more than 93 percent of the time, the agency said.

The Vitek MS is manufactured by bioMerieux Inc of Durham, N.C.

More information: The FDA has more about this approval.

add to favorites email to friend print save as pdf

Related Stories

Vibativ approved for certain bacterial pneumonia

Jun 24, 2013

(HealthDay)—The antibiotic Vibativ (telavancin) has been approved by the U.S. Food and Drug Administration to treat pneumonia caused by Staphylococcus aureus bacteria when other treatments aren't suitable.

Blood-tracking device uses new technology

May 29, 2013

(HealthDay)—The first device to use Radio Frequency Identification (RFID) technology to help workers track blood products and prevent the release of unsuitable samples has been approved by the U.S. Food and Drug Administration.

New drugs, diagnostic approved for advanced melanoma

May 29, 2013

(HealthDay)—Two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), have been approved by the U.S. Food and Drug Administration to treat advanced melanoma, the most dangerous form of skin cancer.

New test IDs genotype of hepatitis C

Jun 20, 2013

(HealthDay)—A new test to help doctors identify the genotype of a person's hepatitis C infection has been approved by the U.S. Food and Drug Administration.

Kcentra approved to stop severe bleeding in heart patients

Apr 30, 2013

(HealthDay)—Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the anti-clotting drug warfarin and ...

Recommended for you

Three weeks since last Ebola case in Mali: WHO

57 minutes ago

Mali has not had a case of Ebola for three weeks, the World Health Organization said Wednesday, completing one of the two incubation periods the country needs to be declared free of the virus.

Migraine may double risk for facial paralysis

1 hour ago

Migraine headache may double the risk of a nervous system condition that causes facial paralysis, called Bell's palsy, according to a new study published in the December 17, 2014, online issue of Neurology, the medical journa ...

Anti-diabetic drug springs new hope for tuberculosis patients

8 hours ago

A more effective treatment for tuberculosis (TB) could soon be available as scientists have discovered that Metformin (MET), a drug for treating diabetes, can also be used to boost the efficacy of TB medication without inducing ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.